Association between use of non–vitamin k oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation
Importance: Non–vitamin K oral anticoagulants (NOACs) are commonly prescribed with other medications that share metabolic pathways that may increase major bleeding risk. Objective: To assess the association between use of NOACs with and without concurrent medications and risk of major bleeding...
| Main Authors: | Chang, Shang-Hung, Chou, I-Jun, Yeh, Yung-Hsin, Chiou, Meng-Jiun, Wen, Ming-Shien, Kuo, Chi-Tai, See, Lai-Chu, Kuo, Chang-Fu |
|---|---|
| Format: | Article |
| Published: |
American Medical Association
2017
|
| Online Access: | https://eprints.nottingham.ac.uk/48181/ |
Similar Items
Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016)
by: Bista, D., et al.
Published: (2016)
Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)
by: Kuo, Chang-Fu, et al.
Published: (2016)
Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018)
by: Obamiro, K., et al.
Published: (2018)
Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018)
by: Obamiro, K., et al.
Published: (2018)
Percentage of time in therapeutic range and proportion of thromboembolic event in nonvalvular atrial fibrillation patient on warfarin
by: Mohd, Fahmi Nazrin
Published: (2015)
by: Mohd, Fahmi Nazrin
Published: (2015)
Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)
by: Admassie, E., et al.
Published: (2017)
Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)
by: Admassie, E., et al.
Published: (2017)
Efficacy and safety of warfarin in geriatric patient with nonvalvular atrial fibrillation in Hospital Tuanku Ja’afar Seremban / Aslina Ashaari
by: Ashaari, Aslina
Published: (2017)
by: Ashaari, Aslina
Published: (2017)
A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
by: Obamiro, K., et al.
Published: (2016)
by: Obamiro, K., et al.
Published: (2016)
The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
by: Alamneh, E., et al.
Published: (2017)
by: Alamneh, E., et al.
Published: (2017)
Suboptimal use of oral anticoagulants in atrial fibrillation: Has the introduction of direct oral anticoagulants improved prescribing practices?
by: Alamneh, E., et al.
Published: (2016)
by: Alamneh, E., et al.
Published: (2016)
A comparison of dabigatran and warfarin for stroke prevention in elderly Asian population with nonvalvular atrial fibrillation: an audit of current practice in Malaysia
by: Yap, Swee Hien, et al.
Published: (2017)
by: Yap, Swee Hien, et al.
Published: (2017)
Systematic review of adherence to direct oral anticoagulants in patients with atrial fibrilation in clinical practice
by: Kubas, Mohammed Abdullah, et al.
Published: (2018)
by: Kubas, Mohammed Abdullah, et al.
Published: (2018)
Use of anticoagulants and antiplatelet agents in stable outpatients with coronary artery disease and atrial fibrillation. International clarify registry
by: Fauchier, L., et al.
Published: (2015)
by: Fauchier, L., et al.
Published: (2015)
Assessing adherence to direct oral anticoagulants (DOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia
by: Kubas, Mohammed Abdullah, et al.
Published: (2019)
by: Kubas, Mohammed Abdullah, et al.
Published: (2019)
The relationship between knowledge, health literacy, and adherence among patients taking oral anticoagulants for stroke thromboprophylaxis in atrial fibrillation
by: Rolls, C., et al.
Published: (2017)
by: Rolls, C., et al.
Published: (2017)
Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)
by: Taggar, Jaspal
Published: (2017)
Assessing adherence and persistence to non-vitamin k antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia
by: Kubas, Mohammed A., et al.
Published: (2020)
by: Kubas, Mohammed A., et al.
Published: (2020)
Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
by: Admassie, E., et al.
Published: (2018)
by: Admassie, E., et al.
Published: (2018)
Gastrointestinal bleeding risk assessment using HAS-Bled in atrial fibrillation patients who are receiving warfarin in Hospital Universiti Sains Malaysia
by: Idris, Sri Salwani
Published: (2018)
by: Idris, Sri Salwani
Published: (2018)
Gastrointestinal bleeding risk assessment using HAS-Bled in atrial fibrillation patients who are receiving warfarin in Hospital Universiti Sains Malaysia
by: Idris, Sri Salwani Idris
Published: (2018)
by: Idris, Sri Salwani Idris
Published: (2018)
ENVIRONMENTAL SUSTAINABILITY APPRAISAL OF THE ATRIAL FIBRILLATION CARE PATHWAY
by: Munawar, Sana
Published: (2016)
by: Munawar, Sana
Published: (2016)
Screening for atrial fibrillation in primary care: from recommendation to implementation
by: Taggar, Jaspal, et al.
Published: (2016)
by: Taggar, Jaspal, et al.
Published: (2016)
Stroke prevention in atrial fibrillation: An update on current management strategies
by: Hall, Toby, et al.
Published: (2013)
by: Hall, Toby, et al.
Published: (2013)
Incidence of major bleeding among oral anticoagulants / Ziran Nadiah Ghazali
by: Ghazali, Ziran Nadiah
Published: (2017)
by: Ghazali, Ziran Nadiah
Published: (2017)
Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores
by: Hippisley-Cox, Julia, et al.
Published: (2014)
by: Hippisley-Cox, Julia, et al.
Published: (2014)
Knowledge of atrial fibrillation and stroke prevention: development of questionnaire and validation of results
by: Mohamed, Sahimi, et al.
Published: (2017)
by: Mohamed, Sahimi, et al.
Published: (2017)
Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
by: Bista, D., et al.
Published: (2017)
by: Bista, D., et al.
Published: (2017)
Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results
by: Sahimi, Mohamed, et al.
Published: (2016)
by: Sahimi, Mohamed, et al.
Published: (2016)
Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)
The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients
by: Russell, E., et al.
Published: (2017)
by: Russell, E., et al.
Published: (2017)
Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region
by: Bimbo Diaz, Alejandro, et al.
Published: (2023)
by: Bimbo Diaz, Alejandro, et al.
Published: (2023)
Epidemiology of gout in the United Kingdom and Taiwan
by: Kuo, Chang-Fu
Published: (2014)
by: Kuo, Chang-Fu
Published: (2014)
Successful intravenous thrombolysis of a wake-up stroke with underlying valvular atrial fibrillation
by: Koya Kutty, Shahedah, et al.
Published: (2018)
by: Koya Kutty, Shahedah, et al.
Published: (2018)
Screening for atrial fibrillation – a cross-sectional survey of healthcare professionals in primary care
by: Taggar, Jaspal, et al.
Published: (2016)
by: Taggar, Jaspal, et al.
Published: (2016)
Postoperative atrial fibrillation after isolated aortic valve replacement: A cause for concern?
by: Saxena, A., et al.
Published: (2013)
by: Saxena, A., et al.
Published: (2013)
Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: The Atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2012)
by: Huxley, Rachel, et al.
Published: (2012)
Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: The atherosclerosis risk in communities study
by: Chen, L., et al.
Published: (2014)
by: Chen, L., et al.
Published: (2014)
Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart study
by: Alonso, A., et al.
Published: (2014)
by: Alonso, A., et al.
Published: (2014)
Physical activity, obesity, weight change, and risk of atrial fibrillation the atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2014)
by: Huxley, Rachel, et al.
Published: (2014)
Similar Items
-
Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016) -
Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016) -
Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018) -
Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018) -
Percentage of time in therapeutic range and proportion of thromboembolic event in nonvalvular atrial fibrillation patient on warfarin
by: Mohd, Fahmi Nazrin
Published: (2015)